and phenotypic profiles of individuals in South Africa. We recruited a cohort of 4 0 6 children with ASD which were age-and gender-matched to typically developing 4 0 7 controls. Given that methylation levels at some genes are associated with age (64), 4 0 8 our age range was restricted to pre-pubertal children (6-12 years old) (65). Due to 4 0 9 the higher genetic load and co-morbidities present in girls with ASD (66,67), we 4 1 0 focused on boys only, in order to reduce the genetic heterogeneity in our cohort. Furthermore, only children with a prior independent diagnosis of ASD and without 4 1 2 known co-morbidities were recruited into our case group; these children all attended Moderate to Severe according to the ADOS-2 scale. Our ASD cohort is therefore schools. In addition, the control cohort was screened for the complete absence of 4 2 1 any of the traits that define ASD using ADOS-2. All ADOS assessments were done Study participants and tissue collection. We screened 127 children, 72 cases and 4 2 6 55 controls, using ADOS-2 over a four-year period (2014) (2015) (2016) (2017) . Prior to recruiting, was obtained for each participant after we explained our study via oral and written confounding factor of cellular heterogeneity, we used DNA extracted from buccal 4 3 5 cells because these reflect DNA methylation of brain more accurately than blood 4 3 6 cells (68, 69) . Buccal cells were collected using Epicentre Catch-All TM collection 4 3 7
swabs. DNA was extracted using Proteinase K/ Salting out, followed by EtOH to other methylome studies that were recently published (27, 71) , and reflects the beadchip assay. Genome-wide methylation was assessed using the Illumina Infinium was completed using the function wateRmelon::pfilter to flag low quality samples were then used to assess blood cell composition differences 4 6 0 (minfi::estimateCellCounts) and normalized using SWAN (missMethyl::SWAN) (76).
6 1
We then applied a sequence of filters to remove probes that had a detection p-value 4 6 2 > 0.01 in at least one sample, probes that contained known SNPs these normalized data (with offset 100). Differences in methylation probe levels were 4 6 7 obtained using the RUV-2 method (78), using Illumina 450k array negative controls 2  8  2  6  6  7  9  1  5  9  3   5  .  L  o  r  d  C  ,  B  i  s  h  o  p  S  L  .  R  e  c  e  n  t  a  d  v  a  n  c  e  s  i  n  a  u  t  i  s  m  r  e  s  e  a  r  c  h  a  s  r  e  f  l  e  c  t  e  d  i  n  D  S  M  -5  c  r  i  t  e  r  i  a  f  o  r  5  9  4  a  u  t  i  s  m  s  p  e  c  t  r  u  m  d  i  s  o  r  d  e  r  .  A  n  n  u  R  e  v  C  l  i  n  P  s  y  c  h  o  l  .  2  0  1  5  ;  1  1  :  5  3  -7  0  .  5  9  5   6 . A  n  i  n  v  e  s  t  i  g  a  t  i  o  n  o  f  c  o  m  o  r  b  i  d  p  s  y  c  h  o  l  o  g  i  c  a  l  d  i  s  o  r  d  e  r  s  ,  s  l  e  e  p  p  r  o  b  l  e  m  s  ,  6  0  0  g  a  s  t  r  o  i  n  t  e  s  t  i  n  a  l  s  y  m  p  t  o  m  s  a  n  d  e  p  i  l  e  p  s  y  i  n  c  h  i  l  d  r  e  n  a  n  d  a  d  o  l  e  s  c  e  n  t  s  w  i  t  h  a  u  t  i  s  m  s  p  e  c  t  r  u  m  d  i  s  o  r  d  e  r  :  6  0  1  A  t  w  o  y  e  a  r  f  o  l  l  o  w  -u  p  .  R  e  s  A  u  t  i  s  m  S  p  e  c  t  r  D  i  s  o  r  d  .  2  0  1  6  ;  2  2  :  2  0  -3  3  .  6  0  2   9  .  G  a  n  d  a  l  M  J  ,  H  a  n  e  y  J  R  ,  P  a  r  i  k  s  h  a  k  N  N  ,  L  e  p  p  a  V  ,  R  a  m  a  s  w  a  m  i  G  ,  H  a  r  t  l  C  ,  e  t  a  l  .  S  h  a  r  e  d  m  o  l  e  c  u  l  a  r  6  0  3  n  e  u  r  o  p  a  t  h  o  l  o  g  y  a  c  r  o  s  s  m  a  j  o  r  p  s  y  c  h  i  a  t  r  i  c  d  i  s  o  r  d  e  r  s  p  a  r  a  l  l  e  l  s  p  o  l  y  g  e  n  i  c  o  v  e  r  l  a  p  .  S  c  i  e  n  c  e  .  2  0  1  8  F  e  b  6  0  4  9  ;  3  5  9  (  6  3  7  6  )  :  6  9  3  .  6  0  5   2  2   1  0  .  V  o  i  n  e  a  g  u  I  .  G  e  n  e  e  x  p  r  e  s  s  i  o  n  s  t  u  d  i  e  s  i  n  a  u  t  i  s  m  :  m  o  v  i  n  g  f  r  o  m  t  h  e  g  e  n  o  m  e  t  o  t  h  e  6  0  6  t  r  a  n  s  c  r  i  p  t  o  m  e  a  n  d  b  e  y  o  n  d  .  N  e  u  r  o  b  i  o  l  D  i  s  .  2  0  1  2  J  a  n  ;  4  5  (  1  )  :  6  9  -7  5  .  6  0  7   1  1  .  G  a  r  b  e  t  t  K  ,  E  b  e  r  t  P  J  ,  M  i  t  c  h  e  l  l  A  ,  L  i  n  t  a  s  C  ,  M  a  n  z  i  B  ,  M  i  r  n  i  c  s  K  ,  e  t  a  l  .  I  m  m  u  n  e  t  r  a  n  s  c  r  i  p  t  o  m  e  6  0  8  a  l  t  e  r  a  t  i  o  n  s  i  n  t  h  e  t  e  m  p  o  r  a  l  c  o  r  t  e  x  o  f  s  u  b  j  e  c  t  s  w  i  t  h  a  u  t  i  s  m  .  N  e  u  r  o  b  i  o  l  D  i  s  .  2  0  0  8  J  u  n  ;  3  0  (  3  )  :  3  0  3  -1  1  .  6  0  9   1  2  .  C  h  o  w  M  L  ,  P  r  a  m  p  a  r  o  T  ,  W  i  n  n  M  E  ,  B  a  r  n  e  s  C  C  ,  L  i  H  -R  ,  W  e  i  s  s  L  ,  e  t  a  l  .  A  g  e  -D  e  p  e  n  d  e  n  t  B  r  a  i  n  6  1  0  G  e  n  e  E  x  p  r  e  s  s  i  o  n  a  n  d  C  o  p  y  N  u  m  b  e  r  A  n  o  m  a  l  i  e  s  i  n  A  u  t  i  s  m  S  u  g  g  e  s  t  D  i  s  t  i  n  c  t  P  a  t  h  o  l  o  g  i  c  a  l  P  r  o  c  e  s  s  e  s  a  t  6  1  1  Y  o  u  n  g  V  e  r  s  u  s  M  a  t  u  r  e  A  g  e  s  .  P  L  O  S  G  e  n  e  t  .  2  0  1  2  M  a  r  2  2  ;  8  (  3  )  :  e  1  0  0  2  5  9  2  .  6  1  2   1  3 . 6  2  5  2  0  1  7  ;  2  0  1  7  :  1  2  .  6  2  6   1  9  .  B  o  s  e  A  ,  B  e  a  l  M  F  .  M  i  t  o  c  h  o  n  d  r  i  a  l  d  y  s  f  u  n  c  t  i  o  n  i  n  P  a  r  k  i  n  s  o  n  '  s  d  i  s  e  a  s  e  .  J  N  e  u  r  o  c  h  e  m  .  6  2  7  2  0  1  6  ;  1  3  9  :  2  1  6  -3  1  .  6  2  8   2  0  .  F  r  a  n  c  o  -I  b  o  r  r  a  S  ,  V  i  l  a  M  ,  P  e  r  i  e  r  C  .  T  h  e  P  a  r  k  i  n  s  o  n  D  i  s  e  a  s  e  M  i  t  o  c  h  o  n  d  r  i  a  l  H  y  p  o  t  h  e  s  i  s  :  W  h  e  r  e  6  2  9  A  r  e  W  e  a  t  ?  T  h  e  N  e  u  r  o  s  c  i  e  n  t  i  s  t  .  2  0  1  6  ;  2  2  (  3  )  :  2  6  6  -7  7  .  6  3  0   2  1  .  M  a  t  i  l  a  i  n  e  n  O  ,  Q  u  i  r  ó  s  P  M  ,  A  u  w  e  r  x  J  .  M  i  t  o  c  h  o  n  d  r  i  a  a  n  d  E  p  i  g  e  n  e  t  i  c  s  -C  r  o  s  s  t  a  l  k  i  n  6  3  1  H  o  m  e  o  s  t  a  s  i  s  a  n  d  S  t  r  e  s  s  .  T  r  e  n  d  s  C  e  l  l  B  i  o  l  .  2  0  1  7  J  u  n  1  ;  2  7  (  6  )  :  4  5  3  -6  3  .  6  3  2   2  2 . . . . .
